\-\ Texto\\:\\ \ \(0\)\
\-\ pertinant\\ positives\\:\\ subtle\\ left\\ facial\\ droop\ \(0\)\
\-\ the\\ initial\\ treatment\\ of\\ choice\\ for\\ glioblastoma\\ multiforme\\ is\\ surgical\\ resection\\ with\\ maximal\\ preservation\\ of\\ neurological\\ function\\.\\ however\\,\\ few\\ if\\ any\\ patients\\ are\\ cured\\ with\\ surgery\\ alone\\.\\ therefore\\,\\ adjuvant\\ focal\\ external\\ beam\\ radiation\\ therapy\\ along\\ with\\ chemotherapy\\ is\\ usually\\ added\\.\\ the\\ median\\ survival\\ rate\\ with\\ supportive\\ care\\ is\\ 14wks\\,\\ 20wks\\ with\\ resectionn\\ alone\\,\\ 36wks\\ for\\ surgery\\ with\\ radiation\\ therapy\\,\\ and\\ 40\\-50wks\\ with\\ the\\ addition\\ of\\ chemotherapy\\.\ \(0\)\
\-\ 4cm\\ hypervascular\\ rim\\ located\\ in\\ the\\ right\\ parietal\\ region\ \(1\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ primary\\ central\\ nervous\\ system\\ lymphoma\ \(0\)\
\-\ brain\\ metastases\ \(1\)\
\-\ brain\\ abscess\ \(13\)\
\-\ cerebral\\ infarction\ \(29\)\
\-\ hemorrhagic\\ vascular\\ disease\ \(0\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ cysticercosis\ \(25\)\
\-\ patient\\ with\\ history\\ of\\ hypertension\\,\\ osteoarthritis\\ and\\ hyperlipidemia\\ presents\\ with\\ one\\ month\\ history\\ of\\ gait\\ disturbance\\,\\ requiring\\ cane\\.\\ progresses\\ to\\ left\\ facial\\ droop\\ and\\ left\\ lower\\ extremity\\ weakness\\.\ \(0\)\
\-\ glioblastoma\\ multiformes\\ are\\ cns\\ neoplasms\\ derived\\ from\\ immortalized\\ astrocytes\\.\\ they\\ occur\\ in\\ all\\ ages\\ with\\ peak\\ at\\ 65\\-75\\ years\\ of\\ age\\.\\ the\\ are\\ more\\ common\\ in\\ men\\ \\(men\\ \\>\\ women\\ 3\\:2\\)\\,\\ and\\ more\\ common\\ in\\ whites\\.\\ the\\ most\\ common\\ presenting\\ symptom\\ is\\ headache\\,\\ followed\\ by\\ memory\\ loss\\,\\ motor\\ weakness\\,\\ visual\\ symptoms\\,\\ language\\ deficit\\,\\ and\\ cognitive\\/personality\\ changes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ glioblastoma\\:\\ 0\\.06720920799704552\ \(0\)\
\-\ droop\\:\\ 0\\.05591504233142913\ \(0\)\
\-\ multiforme\\:\\ 0\\.04728924592625181\ \(0\)\
\-\ men\\:\\ 0\\.045966994070497376\ \(0\)\
\-\ alone\\:\\ 0\\.044055844589905455\ \(0\)\
\-\ pertinant\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ 14wks\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ 20wks\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ resectionn\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ 36wks\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ 40\\-50wks\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ multiformes\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ immortalized\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ cognitive\\/personality\\:\\ 0\\.04197865916174524\ \(0\)\
\-\ astrocytes\\:\\ 0\\.03867795830193597\ \(0\)\
\-\ 65\\-75\\:\\ 0\\.03867795830193597\ \(0\)\
\-\ 3\\:2\\:\\ 0\\.03674717207284947\ \(0\)\
\-\ facial\\:\\ 0\\.035387161868021905\ \(0\)\
\-\ positives\\:\\ 0\\.03344647121304021\ \(0\)\
\-\ language\\:\\ 0\\.03344647121304021\ \(0\)\
\-\ common\\:\\ 0\\.031946674456519955\ \(0\)\
\-\ cured\\:\\ 0\\.03151568498395371\ \(0\)\
\-\ cane\\:\\ 0\\.03151568498395371\ \(0\)\
\-\ whites\\:\\ 0\\.031013968242725967\ \(0\)\
\-\ weakness\\:\\ 0\\.03022487002884176\ \(0\)\
\-\ derived\\:\\ 0\\.029411719496910668\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.029170912239436814\ \(0\)\
\-\ disturbance\\:\\ 0\\.029083182013639467\ \(0\)\
\-\ added\\:\\ 0\\.028775855722508178\ \(0\)\
\-\ beam\\:\\ 0\\.027480933267824168\ \(0\)\
\-\ adjuvant\\:\\ 0\\.02725940938384849\ \(0\)\
\-\ progresses\\:\\ 0\\.02725940938384849\ \(0\)\
\-\ nervous\\:\\ 0\\.027047734323987375\ \(0\)\
\-\ memory\\:\\ 0\\.027047734323987375\ \(0\)\
\-\ radiation\\:\\ 0\\.02670715475773654\ \(0\)\
\-\ maximal\\:\\ 0\\.026463913742595314\ \(0\)\
\-\ 4cm\\:\\ 0\\.02628419789505795\ \(0\)\
\-\ cysticercosis\\:\\ 0\\.02532862315476199\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.02518646618738256\ \(0\)\
\-\ preservation\\:\\ 0\\.025048430297509926\ \(0\)\
\-\ brain\\:\\ 0\\.024489062126692974\ \(0\)\
\-\ hypervascular\\:\\ 0\\.024068182420347313\ \(0\)\
\-\ median\\:\\ 0\\.02354436863361242\ \(0\)\
\-\ peak\\:\\ 0\\.02316321288278605\ \(0\)\
\-\ ages\\:\\ 0\\.023072507192449417\ \(0\)\
\-\ symptom\\:\\ 0\\.023072507192449417\ \(0\)\
\-\ requiring\\:\\ 0\\.022481780294020943\ \(0\)\
\-\ survival\\:\\ 0\\.021816247235091613\ \(0\)\
\-\ therapy\\:\\ 0\\.021758483773720125\ \(0\)\
\-\ choice\\:\\ 0\\.021052710806162188\ \(0\)\
\-\ deficit\\:\\ 0\\.020994281793820214\ \(0\)\
\-\ cns\\:\\ 0\\.02082317698798182\ \(0\)\
\-\ neoplasms\\:\\ 0\\.020712430025294833\ \(0\)\
\-\ more\\:\\ 0\\.0203540600886873\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.02019432116887198\ \(0\)\
\-\ women\\:\\ 0\\.01977180633264015\ \(0\)\
\-\ surgery\\:\\ 0\\.01976189585105024\ \(0\)\
\-\ therefore\\:\\ 0\\.019220928242166518\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.01898668898411523\ \(0\)\
\-\ gait\\:\\ 0\\.018948745319119147\ \(0\)\
\-\ subtle\\:\\ 0\\.018691282360689263\ \(0\)\
\-\ visual\\:\\ 0\\.018447028577891402\ \(0\)\
\-\ few\\:\\ 0\\.018312881544716657\ \(0\)\
\-\ supportive\\:\\ 0\\.01799317057882319\ \(0\)\
\-\ neurological\\:\\ 0\\.01760726005499878\ \(0\)\
\-\ parietal\\:\\ 0\\.017384440238299926\ \(0\)\
\-\ metastases\\:\\ 0\\.017384440238299926\ \(0\)\
\-\ external\\:\\ 0\\.01730349939844959\ \(0\)\
\-\ function\\:\\ 0\\.01725029320512518\ \(0\)\
\-\ addition\\:\\ 0\\.01725029320512518\ \(0\)\
\-\ rim\\:\\ 0\\.017223911393812727\ \(0\)\
\-\ motor\\:\\ 0\\.016992830246695297\ \(0\)\
\-\ \\,\\:\\ 0\\.016758242151070173\ \(0\)\
\-\ located\\:\\ 0\\.01674857646389744\ \(0\)\
\-\ are\\:\\ 0\\.016641055321851454\ \(0\)\
\-\ infarction\\:\\ 0\\.016630992594419476\ \(0\)\
\-\ presenting\\:\\ 0\\.016584760146195855\ \(0\)\
\-\ hypertension\\:\\ 0\\.0160418145347628\ \(0\)\
\-\ system\\:\\ 0\\.016021333192384753\ \(0\)\
\-\ rate\\:\\ 0\\.015860578526075444\ \(0\)\
\-\ occur\\:\\ 0\\.015266888708483518\ \(0\)\
\-\ extremity\\:\\ 0\\.014881709379249704\ \(0\)\
\-\ care\\:\\ 0\\.014677034033660727\ \(0\)\
\-\ they\\:\\ 0\\.014661648221368126\ \(0\)\
\-\ sclerosis\\:\\ 0\\.014615786825839739\ \(0\)\
\-\ cerebral\\:\\ 0\\.014097364294114624\ \(0\)\
\-\ headache\\:\\ 0\\.013976121131265706\ \(0\)\
\-\ left\\:\\ 0\\.013658646703898781\ \(0\)\
\-\ followed\\:\\ 0\\.013642266054184627\ \(0\)\
\-\ \\>\\:\\ 0\\.013519845307945547\ \(0\)\
\-\ initial\\:\\ 0\\.01348372449180623\ \(0\)\
\-\ along\\:\\ 0\\.013447875604088173\ \(0\)\
\-\ central\\:\\ 0\\.013388720746952187\ \(0\)\
\-\ vascular\\:\\ 0\\.013341920323446176\ \(0\)\
\-\ abscess\\:\\ 0\\.012865886876829845\ \(0\)\
\-\ any\\:\\ 0\\.012813500157487114\ \(0\)\
\-\ resection\\:\\ 0\\.01269007455009628\ \(0\)\
\-\ age\\:\\ 0\\.012385287264496699\ \(0\)\
\-\ usually\\:\\ 0\\.01235680120888933\ \(0\)\
\-\ month\\:\\ 0\\.012207688289526713\ \(0\)\
\-\ primary\\:\\ 0\\.012054210775693793\ \(0\)\
\-\ years\\:\\ 0\\.011948776842945156\ \(0\)\
\-\ loss\\:\\ 0\\.011811734154611618\ \(0\)\
\-\ changes\\:\\ 0\\.011662133220166956\ \(0\)\
\-\ lymphoma\\:\\ 0\\.011629517306616599\ \(0\)\
\-\ focal\\:\\ 0\\.011621398114944772\ \(0\)\
\-\ all\\:\\ 0\\.011509159473482338\ \(0\)\
\-\ region\\:\\ 0\\.01149333917733006\ \(0\)\
\-\ however\\:\\ 0\\.011330324074271765\ \(0\)\
\-\ history\\:\\ 0\\.011240138454353177\ \(0\)\
\-\ if\\:\\ 0\\.011041635398955408\ \(0\)\
\-\ one\\:\\ 0\\.01102729230147926\ \(0\)\
\-\ is\\:\\ 0\\.010710300540661442\ \(0\)\
\-\ patients\\:\\ 0\\.010531307616028695\ \(0\)\
\-\ symptoms\\:\\ 0\\.01014122608046733\ \(0\)\
\-\ most\\:\\ 0\\.009394453055847981\ \(0\)\
\-\ lower\\:\\ 0\\.009151724139827918\ \(0\)\
\-\ multiple\\:\\ 0\\.00857050477847271\ \(0\)\
\-\ surgical\\:\\ 0\\.008553437001197399\ \(0\)\
\-\ presents\\:\\ 0\\.008312591883371077\ \(0\)\
\-\ treatment\\:\\ 0\\.0082362712361947\ \(0\)\
\-\ in\\:\\ 0\\.008026613907433427\ \(0\)\
\-\ for\\:\\ 0\\.006943887129930621\ \(0\)\
\-\ by\\:\\ 0\\.006775575729737499\ \(0\)\
\-\ disease\\:\\ 0\\.006651131148646211\ \(0\)\
\-\ from\\:\\ 0\\.006030646253115298\ \(0\)\
\-\ with\\:\\ 0\\.0055716274328518915\ \(0\)\
\-\ at\\:\\ 0\\.005513157870626824\ \(0\)\
\-\ \\:\\:\\ 0\\.005382261028526977\ \(0\)\
\-\ right\\:\\ 0\\.004293484329097223\ \(0\)\
\-\ and\\:\\ 0\\.004285928707909963\ \(0\)\
\-\ patient\\:\\ 0\\.004079009194839943\ \(0\)\
\-\ the\\:\\ 0\\.003949979562960737\ \(0\)\
\-\ \\(\\:\\ 0\\.0034398177440183838\ \(0\)\
\-\ \\)\\:\\ 0\\.0033977985338728817\ \(0\)\
\-\ of\\:\\ 0\\.0033286800227996694\ \(0\)\
\-\ to\\:\\ 0\\.002033657659252316\ \(0\)\
\-\ \\.\\:\\ 0\\.001690454099873632\ \(0\)\
